Objective:7o establish the predictive value of an extended spectrum of immunologic parameters measu- red during the initial ICU days on the ICU survival of patients requiring long-term intensive care. Design: Prospective, clinical study. Setting: Department Anaesthesia and Intensive Care, St. Anna University Hospital, Brno, Czech Republic. Materiál and methods:The immune profile was taken in patients estimated to stay in the ICU > 3 days in 5- day intervals. In this páper we report on the trends of TNF-alpha production of the whole blood after LPS stimulation (TNF-alpha), plasma IL-6 and IL-10 concentrations and T-lymphocyte activation (CD3+HLA- DR+) in the first 5 days of ICU stay. The relationship of the immunologic parameters to ICU mortality, type of admission (surgical, medical, trauma, CPR) and APACHE II is also reported. Results: 167 patients were studied [M/F 113/54; mean age 63 (53; 73) years]. 137 survived their ICU stay (S) and 30 died (NS). APACHE II on admission was 27 (21; 33). On day 1 the production of TNF-alpha differed in the S and NS groups [> 1000 pg/ml (752; > 1000) and 870 pg/ml (542; > 1000) respectively; p < 0.05] as did the IL-10 concentration [6.2 pg/ml (5; 18) and 19 pg/ml (5.4; 63) respectively; p=0.005]. In the patients remaining in the ICU on day 5 (n=125) the change in TNF-a between day 1 and day 5 (delta TNF-a) did not differ between the S and NS groups.There was no significant difference betweenTNF-alpha between the S and NS groups on day 5 [in group S TNF-alpha production increased from > 1000 pg/ml (752; > 1000) to > 1000 pg/ml (> 1000; > 1000) and in group NS from 870 pg/ml (542; >1000) to > 1000 pg/ml (785; > 1000)]. IL-6 decreased in the NS group more slowly and therefore a significant difference in con- centrations on day 5 was measured (p = 0.001). In group S a decrease from 74 pg/ml (32; 178) to 29.8 pg/ml (14.1; 57.4) and in group NS from 88 pg/ml (34; 681) to 66.5 pg/ml (43; 109) was measured. Patients with TNF-alpha production < 1000 pg/ml on day 1 had significantly greater mortality (p < 0.05) as did those with IL-10 > 9.2 pg/ml on day 1 (p = 0.06) and day 5 (p = 0.09). IL-6 >75 pg/ml predicted ICU death. No clinically significant association was found between any immunologic parameter and APACHE II on ICU admission. Conclusion:lbe extended immune spectrum (TNF-alpha production of the whole blood after LPS stimula tion, IL-10 and IL-6 plasma concentrations) has a predictive value in the heterogeneous population of long- term ICU patients.

        Key words: intensive - immunoparalysis -TNF-alpha - interleukin 6 - interleukin 10 - APACHE II - outcome